In a discovery that could reshape how we think about memory, researchers at Flinders University have found that forgetting is not just a glitch in the brain but is actually a finely tuned process, and dopamine is the key.
Phase 2 trial found adding Bevacizumab to different chemotherapy drugs led to more patients’ tumours shrinking, which has helped to change routine UK treatment.
Research team conducts meta-analysis on the potential of diverse pasture lands for dairy farming.
Low cholesterol can reduce the risk of dementia, a new University of Bristol-led study with more than a million participants has shown.
On the edge of California’s Monterey Bay, ecologist Matthew Savoca and a team of volunteers sift through sand and seawater for microplastics, one of the planet’s most pervasive forms of pollution.
Obesity has long been acknowledged as a risk factor for a wide range of diseases, but a more precise link between obesity and Alzheimer’s disease has remained a mystery – until now.
A University of Arizona research team will receive nearly $2.7 million from the NIH's Common Fund Venture Program to advance next-generation imaging technologies that allow deeper, clearer views inside the body without the need for invasive procedures.
Each year, U.S. wastewater treatment plants clean trillions of gallons of water, from what we flush down the toilet to drain down the sink.
Imagine you have just finished a delicious to-go meal or morning coffee, or used the last drop of moisturizer.
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical trial that a low dose of the well-known medicine aspirin halves the risk of recurrence after surgery in patients with colon and rectal cancer with a certain type of genetic alteration in the tumor.
Page 5 of 539
ENN Daily Newsletter
ENN Weekly Newsletter